Zuspan's Scheme Versus an Alternative Magnesium Sulfate Scheme: Randomized Clinical Trial of Magnesium Serum Concentrations
- 12 January 2010
- journal article
- research article
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 29 (1) , 82-92
Abstract
Objective. The purpose of this study was to determine whether magnesium serum concentrations in patients with severe preeclampsia or eclampsia treated with two different magnesium sulfate schemes were different. Methods. Fourteen patients were randomly assigned in the alternative scheme group and 15 in the Zuspan's group. The difference between the groups was that the intravenously administered maintenance dose was done with 1 g/h by continuous intravenous infusion in the Zuspan's group and 2g in bolus every two hours in the alternative scheme. Blood samples were collected previously to treatment and every 15 minutes during four hours after the beginning of treatment. The primary outcome measure was area under the curve and the t-test was used for statistical analysis with level of statistical significance of 5%. The evaluation of the punctual means at all moments in the alternative group was done with the repeated measures analysis of variance. Results. There was no significant difference in the baseline characteristics between groups. In both schemes, magnesium serum concentration reaches a peak within 15 minutes and a new peak was observed after maintenance dose in the alternative scheme. The area under the curve was significantly lower in the alternative scheme than in the Zuspan's scheme (702.1 ± 73.5 mg/dL vs 796.1 ± 94.6 mg/dL). Conclusion. The serum magnesium concentration of this randomized clinical trial doesn't support the use of the alternative scheme of magnesium sulfate to prevent or treat eclampsia.Keywords
This publication has 15 references indexed in Scilit:
- Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trialThe Lancet, 2002
- Magnesium Sulfate in Eclampsia and Pre-EclampsiaClinical Pharmacokinetics, 2000
- Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia TrialThe Lancet, 1995
- A Safer and More Effective Treatment Regimen for EclampsiaAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1994
- Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizuresAmerican Journal of Obstetrics and Gynecology, 1993
- Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: A randomized, placebo-controlled studyAmerican Journal of Obstetrics and Gynecology, 1992
- Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: A preliminary reportAmerican Journal of Obstetrics and Gynecology, 1987
- A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1984
- TREATMENT OF SEVERE PREECLAMPSIA AND ECLAMPSIAClinical Obstetrics and Gynecology, 1966
- Plasma Levels of Magnesium Attained in Magnesium Sulfate Therapy for Preeclampsia and EclampsiaSurgical Clinics of North America, 1957